Dosimetry Comparison of 3D Conformal Radiotherapy and Intensity-modulated Radiotherapy for the Treatment of Brain Tumors: A Meta-Analysis
Abstract
Background: This study aimed to evaluate IMRT and 3D-CRT in the therapy of brain tumor (BT) in relation to dose-volume histograms (DVHs) parameters, such as Heterogeneity Index (HI), Conformity index (CI), Equivalent Uniform Dose (EUD), and mean dose (Dmean) outcomes, including the program for the tumors of the brain and estimate whether a favored procedure can be found through the features of the pretreatment.
Method: A search of the PubMed, Cochrane Library, and Embase datasets from their beginnings from January 2006 to September 2022 was conducted. The authors separately selected and evaluated studies for qualifying criteria and bias risk.
Result and discussion: Seven studies in total were included. Of them, a total of 387 patients were integrated for the Heterogeneity index (HI), Conformity Index (CI), Equivalent Uniform Dose (EUD), and mean dose (Dmean) comparison analysis, which showed 3D-CRT & IMRT with odd ratio (OR) =1.93; 95% confidence interval (95% CI) =1.63, 2.22; and P value=0.00. For brain tumor patients, CI was higher in IMRT than 3D-CRT with OR= 0.72; 95% CI =0.41, 1.03; p value <0.001. EUD was higher in IMRT than 3D-CRT, resulting in an increased overall survival with OR=-0.86; 95% CI =-1.30, 0.42; and p value<0.001. However, no statistically significant variance was perceived in Dmean between 3D-CRT and IMRT.
Conclusion: Our records suggested that IMRT with conventional linacs results in a meaningfully lower regular percentage of brain tumor volumes…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 387 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.